Differential Sensitivity of Glioma- versus Lung Cancer-specific EGFR mutations to EGFR Kinase Inhibitors

Activation of the epidermal growth factor receptor (EGFR) in glioblastoma (GBM) occurs through mutations or deletions in the extracellular (EC) domain. Unlike lung cancers with EGFR kinase domain (KD) mutations, GBMs respond poorly to the EGFR inhibitor erlotinib. Using RNAi, we show that GBM cells...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vivanco, Igor, Robins, H. Ian, Rohle, Daniel, Campos, Carl, Grommes, Christian, Nghiemphu, Phioanh Leia, Kubek, Sara, Oldrini, Barbara, Chheda, Milan G., Yannuzzi, Nicolas, Tao, Hui, Zhu, Shaojun, Iwanami, Akio, Kuga, Daisuke, Dang, Julie, Pedraza, Alicia, Brennan, Cameron W., Heguy, Adriana, Liau, Linda M., Lieberman, Frank, Yung, W.K. Alfred, Gilbert, Mark R., Reardon, David A., Drappatz, Jan, Wen, Patrick Y., Lamborn, Kathleen R., Chang, Susan M., Prados, Michael D., Fine, Howard A., Horvath, Steve, Wu, Nian, Lassman, Andrew B., DeAngelis, Lisa M., Yong, William H., Kuhn, John G., Mischel, Paul S., Mehta, Minesh P., Cloughesy, Timothy F., Mellinghoff, Ingo K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3354723/
https://ncbi.nlm.nih.gov/pubmed/22588883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-11-0284
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky